Shuttle Pharmaceuticals Holdings, Inc., 2025-11-07
An SEC Form D private-offering notice from Gaithersburg, MD, a $2,500,624 filer-stated offering target in Biotech. Filed 2025-11-07. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage pharmaceutical company developing radiation sensitizer drugs and other novel therapies to improve outcomes for cancer patients treated with radiation therapy.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC., 2025-11-18, $10M, Rockville, MD
- Rani Therapeutics Holdings, Inc., 2025-11-10, $60.3M, San Jose, CA
- Cybrary, Inc., 2025-11-17, $4.5M, Riverdale, MD
- Perimetrics, Inc., 2025-11-07, $17.5M, Redmond, WA
- ELIXIRGEN THERAPEUTICS, INC., 2025-11-13, $4M, Baltimore, MD
- Protein Dynamic Solutions, Inc., 2025-11-07, Wilmington, DE
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.